Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-021-00340-z |